InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+65.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by DeVinney Erick Wayne, Vice-Président. Officer active across 1 company, notably Axogen, Inc.. In total, 23 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €16k. History available since 19 July 2021. The latest transaction was filed on 13 September 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations23 total
2,500 shares0Common StockSEC:0000805928-25-000116:0
1,137 shares@ US$16.298.8% of flowCommon StockSEC:0000805928-25-000116:1
2,950 shares0Common StockSEC:0000805928-25-000041:0
24,799 shares0Common StockSEC:0000805928-25-000028:0
2,500 shares0Common StockSEC:0000805928-25-000018:0
2,500 shares0Common StockSEC:0000805928-24-000129:0
3,000 shares0Common StockSEC:0000805928-24-000049:0
50,000 sharesCommon StockSEC:0000805928-24-000031:0
1,579 shares0Common StockSEC:0000805928-23-000140:0
5,900 shares0Common StockSEC:0000805928-23-000030:0
750 shares0Common StockSEC:0000805928-22-000145:0
20,000 shares@ US$5.0954.2% of flowCommon StockSEC:0000805928-22-000133:0
1,579 shares0Common StockSEC:0000805928-22-000092:0
6,000 shares0Common StockSEC:0000805928-22-000028:0
1,181 shares0Common StockSEC:0000805928-22-000008:0
750 shares0Common StockSEC:0000805928-21-000179
750 shares0Common StockSEC:0000805928-21-000179:0
575 shares0Common StockSEC:0000805928-21-000173
575 shares0Common StockSEC:0000805928-21-000173:0
10,000 shares@ US$3.6718.5% of flowCommon StockSEC:0000805928-21-000172
10,000 shares@ US$3.670.0021% mcap50.0% of flowCommon StockSEC:0000805928-21-000172:0
1,580 shares0Common StockSEC:0000805928-21-000148
1,580 shares0Common StockSEC:0000805928-21-000148:0
23 of 23 declarations
About DeVinney Erick Wayne
Erick Wayne DeVinney serves as the Vice President of Peripheral Nerve Science at Axogen, Inc. In this role, he oversees operations related to research and development of innovative solutions for peripheral nerves. DeVinney contributes to the advancement of medical technologies within the company.
